Show simple item record

dc.contributor.authorBell, Jane
dc.contributor.authorPearson, Sallie-Anne
dc.contributor.authorPaget, Simon P
dc.contributor.authorNielsen, Timothy
dc.contributor.authorBuckley, Nicholas A
dc.contributor.authorCollins, John
dc.contributor.authorNassar, Natasha
dc.date.accessioned2019-12-10T05:23:11Z
dc.date.available2019-12-10T05:23:11Z
dc.date.issued2019-12-10
dc.identifier.urihttps://hdl.handle.net/2123/21495
dc.description.abstractThe increased use of strong opioids should be monitored as higher doses have been associated with increased opioid-related adverse events, (such as emergency department visits, hospital admissions and deaths) and opioid use in young populations is associated with future persistent use, non-medical use, and misuseen_AU
dc.language.isoen_AUen_AU
dc.publisherElsevier
dc.rightsThe final version of this paper was published in: The Lancet Child and Adolescent Health 2019; 3(12): 881-8.
dc.subjectopioid useen_AU
dc.subjectAustralian children and adolescentsen_AU
dc.titlePrescription opioid use in Australian children and adolescents: a national population-based studyen_AU
dc.typeArticleen_AU
dc.contributor.departmentMenzies Centre for Health Policyen_AU
dc.identifier.doi10.1016/S2352-4642(19)30329-3


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record